Delivery Order SPE2DB20D1100-SPE2DB25FZ77L

Award Date 12/26/24
Potential Completion Date 1/17/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FZ77L
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,343.59, is for the provision of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 17, 2025. The contract was awarded on December 26, 2024, and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) since 2002. The company specializes in distributing a wide range of pharmaceutical products, medical supplies, and equipment to federal government agencies, particularly within military and veterans' healthcare systems. This contract award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing essential medical commodities to support military healthcare programs globally.

Generated 3/27/25, 10:00 AM